Global Public Health Partnering 2014-2020: Deal trends, players and financials

Global Public Health Partnering 2014-2020: Deal trends, players and financials

Global Public Health Partnering 2014 to 2020 provides the full collection of Public Health disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014.

Trends in Public Health partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Public Health partnering agreement structure
Public Health partnering contract documents
Top Public Health deals by value
Most active Public Health dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Public Health dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Public Health deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Public Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Public Health deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Public Health partnering deals by specific Public Health target announced since 2014. The chapter is organized by specific Public Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Public Health technologies and products.

Report scope

Global Public Health Partnering 2014 to 2020 is intended to provide the reader with an in-depth understanding and access to Public Health trends and structure of deals entered into by leading companies worldwide.

Global Public Health Partnering 2014 to 2020 includes:

Trends in Public Health dealmaking in the biopharma industry since 2014
Analysis of Public Health deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Public Health deal contract documents
Comprehensive access to over 250 Public Health deal records
The leading Public Health deals by value since 2014
Most active Public Health dealmakers since 2014

The report includes deals for the following indications: Addiction, Smoking, Drugs, Alcohol, Health education, Obesity, Preventative medicine, plus other public health indications.

In Global Public Health Partnering 2014 to 2020, available deals and contracts are listed by:

Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Public Health Partnering 2014-2020 report provides comprehensive access to available deals and contract documents for over 250 public health deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in Public Health dealmaking
    • Introduction
    • Public Health partnering over the years
    • Public Health partnering by deal type
    • Public Health partnering by industry sector
    • Public Health partnering by stage of development
    • Public Health partnering by technology type
    • Public Health partnering by therapeutic indication
  • Financial deal terms for Public Health partnering
    • Introduction
    • Disclosed financials terms for Public Health partnering
    • Public Health partnering headline values
      • Table Public Health deals with a headline value
    • Public Health deal upfront payments
      • Table Public Health deals with upfront payment values
    • Public Health deal milestone payments
      • Table Public Health deals with milestone payment
    • Public Health royalty rates
      • Table Public Health deals with royalty rates
  • Leading Public Health deals and dealmakers
    • Introduction
    • Most active in Public Health partnering
    • List of most active dealmakers in Public Health
      • National Institute on Drug Abuse (NIDA)
      • National Institutes of Health
      • BioCorRx
      • Orexigen Therapeutics
      • Titan Pharmaceuticals
      • Novo Nordisk
      • Indivior
      • OptiBiotix
      • ReShape Lifesciences
      • Amygdala Neurosciences
      • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
      • Orexo
      • Academy Medical
      • Adapt Pharma
      • BioDelivery Sciences
      • Lightlake Therapeutics
      • Purdue Pharma
      • Reckitt Benckiser
      • Achieve Life Science
      • Addex Therapeutics
      • Boehringer Ingelheim
      • Braeburn Pharmaceuticals
      • Cerecor
      • Daiichi Sankyo
      • Evotec
    • Top Public Health deals by value
  • Public Health contract document directory
    • Introduction
    • Public Health partnering deals where contract document available
  • Public Health dealmaking by therapeutic target
    • Introduction
    • Deals by Public Health therapeutic target
      • Public Health
      • Addiction
      • Alcohol
      • Drugs
      • Smoking
      • Health education
      • Obesity
      • Preventative medicine
  • Appendices
    • Directory of Public Health deals by company A-Z 2014 to 2020
      • 22nd Century
      • Abic Marketing
      • Academy Medical
      • Academy of Nutrition and Dietetics
      • Accenture
      • Acelrx Pharmaceuticals
      • Achieve Life Science
      • Actavis (acquired by Watson)
      • Acura Pharmaceuticals
      • Adapt Pharma
      • Addex Therapeutics
      • Addiction Institute of Mount Sinai
      • ADL Bionatur Solutions
      • Aetna
      • Agilent Technologies
      • Agropur
      • Aiforia Technologies
      • AIT Laboratories
      • Akers Biosciences
      • Albert Einstein College of Medicine
      • AllianceRx Walgreens Prime
      • Altasciences
      • Altreos Research Partners
      • Alytas Therapeutics
      • Al Danah Medical Company
      • Amarantus BioSciences
      • Amazon Web Services
      • American Dental Association
      • Amneal Pharmaceuticals
      • Amygdala Neurosciences
      • Annum Health
      • Antidote Therapeutics
      • AntiOp
      • Apollo Endosurgery
      • AppianRx
      • Appriss Health
      • Aptuit
      • ARCH Personalized Medicine Initiative
      • Arena Pharmaceuticals
      • AstraZeneca
      • AstraZeneca HealthCare Foundation
      • ATAI Life Sciences
      • AutoGenomics
      • Avista Pharma Solutions
      • Avricore Health
      • Axsome Therapeutics
      • Bain Capital
      • BarioSurg
      • Beacon Discovery
      • BEAM Diagnostics
      • Best Choice
      • BioCorRx
      • BioDelivery Sciences
      • Biohit
      • Biologix FZCo
      • Biomedical Advanced Research and Development Authority
      • BioViva Sciences
      • Boehringer Ingelheim
      • Braeburn Pharmaceuticals
      • Brainsway
      • Brigham and Women's Hospital
      • C4X Discovery
      • California Institute for Biomedical Research
      • Camarus
      • Cambridge Commodities
      • Camino Pharma
      • Canadian Institutes of Health Research
      • Carrum Health
      • Case Western Reserve University
      • Celgene
      • Centene
      • Centers for Disease Control and Prevention
      • Center on Addiction
      • CereCare
      • Cerecor
      • Cerevel Therapeutics
      • Cerner
      • Cheplapharm Arzneimittel
      • Chiesi Farmaceutici
      • Chinmax Medical Systems
      • Christiana Care Health System
      • Chronos Therapeutics
      • Chrono Therapeutics
      • Cigna Healthcare
      • City of Hope
      • Cold Spring Harbor
      • Collective Medical
      • Collegium Pharmaceuticals
      • Columbia University
      • Consilient Health
      • Crown Bioscience
      • CTC Group
      • CVS Caremark
      • D&A Pharma
      • Daiichi Sankyo
      • Delpor
      • DemeRx
      • Dent Neurologic Institute
      • Department of Defense
      • Department of Veterans Affairs
      • Dicerna Pharmaceuticals
      • Doping Control Center
      • Dr. Reddy's Laboratories
      • Duke University
      • DynamiCARE
      • Edico Genome
      • Egalet
      • Eiger BioPharmaceuticals
      • Elithea Sciences
      • Eli Lilly
      • Embark Biotech
      • Embera NeuroTherapeutics
      • Emisphere
      • Emmes
      • Energesis Pharmaceuticals
      • Ensysce Biosciences
      • Enteris Biopharma
      • EnteroMedics
      • Enterome Bioscience
      • Eolas Therapeutics
      • Erasmus University Medical Center
      • Eternygen
      • Ethismos Research
      • Euthymics Bioscience
      • Evonik Industries
      • Evotec
      • Excella
      • Expesicor
      • Express Scripts
      • Facebook
      • Fairview Health System
      • Fannin
      • Fauna Bio
      • Food and Drug Administration (FDA)
      • Gaia BioPharma
      • Galen Data
      • Galmed Pharmaceuticals
      • Gelesis
      • Genentech
      • Genewiz
      • Genomas
      • Gentag
      • Gilead Sciences
      • GlaxoSmithKline
      • Global Center for Health Innovation
      • Global Genomics Group
      • Grunenthal
      • Grupo Juste
      • Gubra
      • Harm Reduction Therapeutics
      • HealthWarehouse
      • Helsinki University Central Hospital (HUCH) Comprehensive Cancer Center
      • Heron Therapeutics
      • Hesperos
      • Highland Pharmaceutical
      • Hisamitsu Pharmaceutical
      • Hy Laboratories
      • IBM
      • India Globalization Capital
      • Indivior
      • Inflexxion
      • Innovent Biologics
      • Inovalon
      • INova Pharmaceuticals
      • Inspirion Delivery Sciences
      • InstaNatural
      • Institute of Human Virology
      • Intarcia Therapeutics
      • Interpace Diagnostics Group
      • Intrexon
      • InVentiv Health
      • Itamar Medical
      • Jackson Laboratory
      • Janssen Pharmaceuticals
      • Janssen Pharmaceutica NV
      • Johnson & Johnson Innovation
      • Johns Hopkins Medicine (JHM)
      • John Morley Foods
      • Joslin Diabetes Center
      • Jubilant Biosys
      • Kaiser Permanente
      • Kallyope
      • KeyBioScience
      • Kinoxis Therapeutics
      • Klaria
      • Knighton Foods
      • Knight Therapeutics
      • Kolar Filtration
      • KSF Acquisition
      • KVK-Tech
      • Kwang Dong Pharmaceutical
      • Laboratory Corporation of America
      • Landeskriminalamt of Lower Saxony
      • LCS Therapeutics
      • Lifeloc Technologies
      • Ligand Pharmaceuticals
      • Lightlake Therapeutics
      • Lucerne Biosciences
      • Lucideon
      • Lupin Limited
      • Lyra Health
      • Marker Test Diagnostics
      • Martindale Pharma
      • Massachusetts General Hospital
      • Maverix Biomics
      • Mayo Clinic
      • MD Anderson Cancer Center
      • MediCann Handels
      • MedicaSafe
      • MediciNova
      • MedImmune
      • Medison Pharma
      • Medix
      • Merck and Co
      • Merck KGaA
      • Metabasis Therapeutics
      • Metabolix
      • Michigan State University
      • Mind Medicine
      • Minneapolis Medical Research Foundation
      • Molecular You
      • Molteni Farmaceutici
      • Montefiore Health System
      • Morel Company
      • Moyer Foundation
      • Mundipharma
      • Nanalysis Scientific
      • NASCO Products
      • National Academy of Medicine
      • National Cancer Institute
      • National Center for Advancing Translational Sciences (NCATS)
      • National Center for Complementary and Integrative Health
      • National Institutes of Health
      • National Institute of Allergy and Infectious Diseases
      • National Institute of Neurological Disorders and Stroke
      • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
      • National Institute on Drug Abuse (NIDA)
      • Navamedic
      • NEMUS Bioscience
      • NeuroSearch
      • Nevada Center For Behavioral Health
      • New York State
      • New York University
      • NGM Biopharmaceuticals
      • NMS Labs
      • Noom
      • North Georgia Healthcare
      • Novartis Consumer Health
      • Novo Nordisk
      • Novu
      • Numab
      • Nutriband
      • Nutricion
      • Obalon Therapeutics
      • OncoGenex Pharmaceuticals
      • Ontario Institute for Cancer Research
      • Opiant Pharmaceuticals
      • Opisafe
      • OptiBiotix
      • Oregon Health Sciences University
      • Orexigen Therapeutics
      • Orexo
      • Ortho-Clinical Diagnostics
      • Pacific Medical
      • Patheon
      • PDL BioPharma
      • PEAR Therapeutics
      • Peptide Logic
      • Perelman School of Medicine
      • Pernix Therapeutics
      • Perrigo
      • Pfizer
      • Pharmathen
      • PinneyAssociates
      • Premier Biomedical
      • Prescient Medical
      • PreveCeutical Medical
      • Productos Medix
      • Publicis Healthcare Communications Group
      • Purdue Pharma
      • Q2i
      • Quintiles
      • Rainbow Coral
      • Reckitt Benckiser
      • ReShape Lifesciences
      • ReShape Medical
      • Rhythm Pharmaceuticals
      • Ro Invest
      • RS EDEN
      • RTI International
      • Salix Pharmaceuticals
      • Samsung Electronics
      • Sandia National Laboratories
      • Sandoz
      • Sanford Burnham Institute
      • Saniona
      • Sanofi
      • Satori
      • Savant HWP
      • Second Genome
      • Selecta Biosciences
      • Semmelweis University
      • Seres Therapeutics
      • Sizewise Worldwide
      • SkyePharma
      • Smith Medical Partners
      • Smoker Friendly International
      • Sono Bello
      • Sosei Heptares
      • Sound Affects Life
      • Spark Biomedical
      • Stanford University
      • StemoniX
      • Stevia First
      • Sun Pharmaceutical
      • Sure med Compliance
      • Targeted Medical Pharma
      • Tenet Diagnostics
      • Teva Pharmaceutical Industries
      • Therakine
      • Thermo Fisher Scientific
      • The Alchemists Kitchen
      • The Obesity Society
      • The Recovery Platform
      • Titan Pharmaceuticals
      • TONIX Pharmaceuticals
      • Trinity Compound Solutions
      • UfaceME
      • UniQuest
      • University of Auckland
      • University of Bristol
      • University of California, San Diego
      • University of Chicago
      • University of Florida
      • University of Houston
      • University of Mississippi
      • University of Oklahoma
      • University of Rochester
      • US Department of Veteran Affairs
      • US WorldMeds
      • Valeant Pharmaceuticals
      • VDM Biochemicals
      • Velabs Therapeutics
      • Viking Therapeutics
      • Vince & Associates Clinical Research
      • Viome
      • Virginia Tech Carilion Research Institute
      • Vitae Pharmaceuticals
      • Vivus
      • Vizient
      • W2O
      • Washington University in St Louis
      • WinterLight Labs
      • WuXi NextCODE Genomics
      • Xenoport
    • Directory of Public Health deals by deal type 2014 to 2020
      • Asset purchase
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Contract Services
      • Co-promotion
      • Development
      • Distribution
      • Equity purchase
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Manufacturing
      • Marketing
      • Option
      • Promotion
      • Research
      • Royalty financing
      • Settlement
      • Spin out
      • Sub-license
      • Supply
      • Technology transfer
    • Directory of Public Health deals by stage of development 2014 to 2020
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Directory of Public Health deals by technology type 2014 to 2020
      • Analysis
      • Animal models
      • Antibodies
      • Bispecific antibodies
      • Monoclonal antibodies
      • Human mAb
      • AI/Artificial intelligence
      • Assays
      • Bioinformatics
      • Biomarkers
      • Clinical testing
      • Devices
      • Surgical devices
      • Wearable devices
      • Diagnostics
      • Imaging
      • In vitro diagnostics
      • Molecular diagnostics
      • Discovery tools
      • High throughput screening (HTS)
      • Drug delivery
      • Implantable
      • Oral delivery
      • Delayed release
      • Rapid release
      • Parenteral
      • Injectable
      • Transdermal
      • Transmucosal
      • Buccal
      • Inhaled
      • Nasal
      • Sublingual
      • Enabling technology
      • Equipment
      • Facilities
      • Gene therapy
      • Genomics
      • Implant
      • Microarray
      • Microbiome
      • Natural product
      • Peptides
      • Personalised medicine
      • Precision medicine
      • Regenerative medicine
      • Research services
      • RNA therapeutics
      • Screening
      • Small molecules
      • Software tools
      • Digital therapeutics
      • Toxicity
      • Vaccines
    • Further reading on dealmaking
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from CurrentPartnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook